Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Dramatic responses to Iressa prompted further bench research. Results have limited clinical relevance, for now, but findings may explain failure of INTACT studies.
This article is from
The Cancer Letter
archive.
Vol. 30 No. 18 | April 30, 2004
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Steven Woolf: Why CMS Should Not Cover LDCT
May 9, 2014
TCL Archive
US Oncology Clarifies Role of Pharmacy Committee
January 24, 2003
TCL Archive
NCAB Commends Garb for His Contributions
December 11, 1981
TCL Archive
R. Lee Clark Clinic Dedication To Honor M.D. Anderson’s “Architect”
November 13, 1987
TCL Archive
Drug Development: Herceptin Associated with 15 Deaths, Genentech Says
May 12, 2000
TCL Archive
Democrats Say Bush Budget Neglects NSF And NASA.
March 23, 2001